Please login to the form below

Not currently logged in


This page shows the latest EGFR news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS

Tagrisso has gained European approval as a first line treatment for lung cancer patients with EGFR mutations, further confirming the drug’s star status among AstraZeneca’s new cancer therapies. ... head-to-head with existing EGFR drugs, Roche’s

Latest news

More from news
Approximately 5 fully matching, plus 137 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    She played a key role in the development and approval of Tagrisso, AstraZeneca’s next-generation EGFR-targeting lung cancer treatment that is proving a major advance on existing reatments, and

  • Harnessing complexity Harnessing complexity

    While more established methodologies still dominate, Next Generation Sequencing is starting to make an impact in the Oncology CDx world, as this breakdown of methodologies used for EGFR mutation testing in

  • Deal Watch November 2015 Deal Watch November 2015

    July finalised a $730m exclusive deal with Boehringer Ingelheim for HM61713, an orally active third generation EGFR agent in small cell lung cancer (SCLC).

  • Transforming times at AstraZeneca Transforming times at AstraZeneca

    in the EGFR-TK gene and Lynparza, which is approved to treat ovarian cancer patients with the BRCA mutation. “

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    These genetic mutations - which also include Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) in lung cancer - have become targets in medicines research, allowing companies new avenues to develop ... lung cancer, which was

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...